National Health Programs & National Immunization Schedule in India
Key Takeaways
India's rural health hierarchy under IPHS operates across three tiers: Sub-Centres / Ayushman Arogya Mandirs (3,000–5,000 population), Primary Health Centres (20,000–30,000 population), and Community Health Centres (80,000–120,000 population acting as First Referral Units).
Grassroots frontline functionaries include ASHAs (1 per 1,000 population, incentive-based health mobilizers), Anganwadi Workers (ICDS supplementary nutrition and child growth monitoring), and Auxiliary Nurse Midwives (multipurpose female workers executing UIP vaccination and maternal care).
The Universal Immunization Programme (UIP) mandates BCG (0.05 mL ID left deltoid), Hepatitis B birth dose (0.5 mL IM left thigh), and OPV-0 at birth, followed by Pentavalent, OPV, fIPV, Rotavirus, and PCV at 6, 10, and 14 weeks.
Cold chain maintenance preserves vaccine viability at +2°C to +8°C in Ice-Lined Refrigerators, with freeze-sensitive vaccines stored in top baskets and evaluated via the Shake Test, while heat-sensitive vaccines carry Vaccine Vial Monitors (VVM).
Under the Open Vial Policy, opened multi-dose vials of Hepatitis B, Pentavalent, OPV, fIPV, PCV, and Td can be reused for up to 28 days, whereas reconstituted live vaccines (BCG, Measles/MR, JE) must be discarded after 4 hours.
The delivery of public health services in India represents one of the largest decentralized healthcare operations in the world. Structured primarily through the National Health Mission (NHM) and guided by the Indian Public Health Standards (IPHS), the public health architecture connects grassroots community mobilizers to specialized multi-specialty secondary and tertiary referral hospitals. For the nursing officer, a thorough mastery of rural health infrastructure, frontline health worker roles, cold chain logistics, and the National Immunization Schedule is indispensable for bedside and public health examinations.
1. Rural Health Care Delivery System in India (IPHS Norms)
The rural healthcare delivery system is organized in a three-tier pyramidal hierarchy comprising the Primary Tier (Sub-Centres and PHCs), Secondary Tier (CHCs and Sub-District Hospitals), and Tertiary Tier (District Hospitals and Government Medical Colleges).
[ District Hospital / Medical College ]
▲
│ (Referral Linkage)
[ Community Health Centre (CHC) ]
(First Referral Unit - FRU)
▲
│ (Referral Linkage)
[ Primary Health Centre (PHC) ]
▲
│ (Outreach & Supervision)
[ Sub-Centre / Ayushman Arogya Mandir (HWC) ]
▲
│ (Village Level)
[ ASHA / Anganwadi Worker (AWW) ]
1. Sub-Centre / Ayushman Bharat – Health and Wellness Centre (HWC) / Ayushman Arogya Mandir
- Population Norms:
- Plain Areas: 5,000 population
- Hilly, Tribal, Desert & Difficult Areas: 3,000 population
- Role & Transformation: The Sub-Centre is the most peripheral point of contact between the rural community and the primary health care system. Under the flagship Ayushman Bharat initiative, all rural and urban sub-centres have been upgraded to Ayushman Arogya Mandirs (Health and Wellness Centres - HWCs) to deliver Comprehensive Primary Health Care (CPHC).
- Staffing:
- 1 Female Health Worker / Auxiliary Nurse Midwife (ANM)
- 1 Male Health Worker / Multipurpose Worker Male (MPW-M)
- 1 Community Health Officer (CHO): A mid-level health provider (B.Sc Nursing or GNM certified with a 6-month Certificate in Community Health / CCH) who leads the HWC team and delivers clinical consultations, non-communicable disease screening, and tele-consultations.
- Scope of Services (12 CPHC Service Packages):
- Care in pregnancy and childbirth
- Neonatal and infant health care services
- Childhood and adolescent healthcare services
- Family planning, contraceptive services, and reproductive health
- Management of communicable diseases (NTEP TB tracking, NVBDCP malaria testing)
- Outpatient management of acute simple illnesses
- Screening, prevention, and management of Non-Communicable Diseases (Hypertension, Diabetes, Oral, Breast, and Cervical Cancers)
- Care for common ophthalmic and ENT conditions
- Basic oral health care
- Elderly and palliative healthcare services
- Emergency medical services including basic trauma and burn care
- Screening and basic management of mental health conditions
2. Primary Health Centre (PHC)
- Population Norms:
- Plain Areas: 30,000 population
- Hilly, Tribal, Desert & Difficult Areas: 20,000 population
- Role: Serves as the first contact point between the rural village community and a fully qualified medical doctor (Medical Officer, MBBS). Acts as an immediate referral center for 6 Sub-Centres.
- Inpatient Beds: 4 to 6 indoor observation beds.
- Staffing (15 Core Staff Members):
- 1 Medical Officer (MBBS)
- 3 to 5 Staff Nurses
- 1 Pharmacist
- 1 Laboratory Technician
- 1 Health Worker Female (Lady Health Visitor - LHV / Health Assistant Female)
- 1 Health Assistant Male (HA-M)
- Clerical, housekeeping, and driver personnel
- Core Functions: Provision of 24/7 basic emergency obstetric care (BEmONC), routine childhood immunization, national health program implementation, primary outpatient and inpatient medical care, minor surgical procedures, water quality surveillance, and vital statistics registration.
3. Community Health Centre (CHC)
- Population Norms:
- Plain Areas: 120,000 population
- Hilly, Tribal, Desert & Difficult Areas: 80,000 population
- Role: The secondary tier referral institution providing specialized medical care for 4 PHCs. Functions as a First Referral Unit (FRU) if it satisfies three critical statutory criteria:
- Round-the-clock (24/7) Comprehensive Emergency Obstetric and Newborn Care (CEmONC) including emergency Caesarean sections.
- 24/7 neonatal intensive care / Special Newborn Care Unit (SNCU) or Newborn Stabilization Unit (NBSU).
- Dedicated operational Blood Storage Facility or blood bank.
- Inpatient Beds: 30 indoor beds with an operation theatre, labor room, X-ray room, and laboratory.
- Specialist Staffing (4 Core Medical Specialists):
- 1 Surgeon (MS)
- 1 Physician (MD General Medicine)
- 1 Obstetrician/Gynecologist (MD/MS DGO)
- 1 Pediatrician (MD/DCH)
- Supported by 1 Anesthetist (or trained MBBS Medical Officer), 10 Staff Nurses, 2 OT Technicians, 1 Radiographer, 2 Laboratory Technicians, 1 Pharmacist, and administrative staff.
2. Grassroots Community Health Functionaries
1. Accredited Social Health Activist (ASHA)
- Program & Norm: Launched under the National Rural Health Mission (NRHM) in 2005. Appointed at the norm of 1 ASHA per 1,000 rural/urban population (relaxed in remote, dispersed tribal hamlets to 1 per habitation).
- Eligibility: A resident woman of the village, married, widowed, or divorced, preferably aged between 25 and 45 years, with formal literacy up to Class 8 to 10 (relaxed only if no literate woman is available).
- Honorary Role: An honorary community health volunteer and social activist. She does not receive a fixed government salary; instead, she receives performance-based monetary incentives tied to specific health outcomes:
- Mobilizing and accompanying pregnant women for institutional delivery under Janani Suraksha Yojana (JSY).
- Tracking and mobilizing infants for complete immunization on Village Health and Nutrition Days (VHND).
- Home-Based Newborn Care (HBNC): Conducting mandatory home visits for newborn care (6 visits for institutional births on days 3, 7, 14, 21, 28, and 42; 7 visits for home births including day 1).
- Distributing condoms, oral contraceptive pills (Chhaya, Mala-N), pregnancy test kits (Nischay), and ORS-Zinc packets.
- Directly Observed Treatment Short-course (DOTS) provider and sputum collection coordinator for presumptive TB.
2. Anganwadi Worker (AWW)
- Program & Ministry: Established under the Integrated Child Development Services (ICDS) scheme (launched on October 2, 1975) under the Ministry of Women and Child Development.
- Population Norm: 1 Anganwadi Worker per 1,000 population (700 in tribal areas; mini-Anganwadi covers 150–300 population).
- Target Beneficiaries: Children under 6 years of age, pregnant women, lactating mothers, and adolescent girls.
- Six Core Services Delivered at Anganwadi Centre:
- Supplementary Nutrition (SNP): Hot cooked meals and Take-Home Rations (THR) to bridge caloric and protein deficits.
- Growth Monitoring: Monthly weighing and plotting of child weights on the WHO child growth chart (Road to Health Chart) to identify Moderate Acute Malnutrition (MAM, yellow zone) and Severe Acute Malnutrition (SAM, red zone).
- Non-Formal Pre-School Education: Cognitive, psychomotor, and social readiness activities for children aged 3 to 6 years.
- Nutrition and Health Education (NHE): Imparting infant and young child feeding (IYCF) counseling to mothers.
- Immunization Facilitation: Coordinating with ANM during monthly VHNDs.
- Referral Services: Referring malnourished or sick infants to Malnutrition Treatment Centres (MTC) or PHCs.
3. Auxiliary Nurse Midwife (ANM)
- Role: The foundational multipurpose female health worker stationed at the Sub-centre / HWC. Holds a formal diploma in Auxiliary Nursing and Midwifery registered with the State Nursing Council.
- Core Clinical Responsibilities:
- Organizes and conducts monthly Village Health and Nutrition Days (VHND) in every village with ASHA and AWW.
- Administers all vaccines under the Universal Immunization Programme (UIP).
- Conducts registered antenatal checkups (ANCs), screens for high-risk pregnancies (anemia, preeclampsia, gestational diabetes), and dispenses Iron-Folic Acid (IFA) and Calcium tablets.
- Executes safe normal deliveries at accredited 24/7 delivery points.
- Administers post-partum care and provides family planning counseling and Intrauterine Contraceptive Device (IUCD / Copper-T) insertions.
3. Universal Immunization Programme (UIP) & National Immunization Schedule (NIS)
India's Universal Immunization Programme (UIP) provides free vaccines against 12 life-threatening vaccine-preventable diseases: Tuberculosis, Diphtheria, Pertussis, Tetanus, Poliomyelitis, Hepatitis B, Haemophilus influenzae type b, Pneumococcal disease, Rotavirus diarrhea, Measles, Rubella, and Japanese Encephalitis (in endemic districts).
Detailed Vaccine Schedule & Administration Protocols
Birth: BCG (0.05 mL ID Left Deltoid) + Hep B Birth (0.5 mL IM Left Thigh) + OPV-0 (2 drops)
6 Weeks: Pentavalent-1 + OPV-1 + fIPV-1 (0.1 mL ID Right Deltoid) + Rota-1 + PCV-1
10 Weeks: Pentavalent-2 + OPV-2 + Rota-2
14 Weeks: Pentavalent-3 + OPV-3 + fIPV-2 (0.1 mL ID Right Deltoid) + Rota-3 + PCV-2
9 Months: MR-1 (0.5 mL SC Right Arm) + fIPV-3 (0.1 mL ID Right Arm) + PCV-Booster + JE-1 (endemic) + Vit A (1 Lakh IU)
16-24 Mos: MR-2 (0.5 mL SC) + DPT-Booster-1 (0.5 mL IM) + OPV-Booster + JE-2 + Vit A (2 Lakh IU)
5-6 Years: DPT-Booster-2 (0.5 mL IM Left Deltoid)
10 & 16 Yrs: Td (0.5 mL IM Upper Arm) [Replaced TT]
1. At Birth
- BCG (Bacillus Calmette-Guérin):
- Type: Live attenuated bacterial vaccine (Mycobacterium bovis, Danish 1331 strain).
- Dose & Route: 0.05 mL until 1 month of age; 0.1 mL if given after 1 month up to 1 year of age. Strictly Intradermal (ID) on the left upper arm at the insertion of the deltoid.
- Syringe: Tuberculin syringe (0.1 mL graduation) with a narrow 26-gauge needle.
- Reconstitution: Reconstituted with Normal Saline (0.9% NaCl). Never use sterile water for injection, as distilled water causes localized tissue irritation and sterile abscesses. Must be discarded after 4 hours.
- Evolution of BCG Scar: Immediate blanched wheal (disappears in 30 minutes) erythematous papule at 2–3 weeks papule ulcerates at 5–6 weeks discharging serous fluid spontaneous healing with a permanent round, pitted, depressed scar at 6–12 weeks.
- Protection: Primarily protects against severe, fatal disseminated forms of childhood TB: tuberculous meningitis and miliary tuberculosis.
- Hepatitis B (Birth Dose):
- Type: Recombinant Hepatitis B surface antigen (HBsAg).
- Dose & Route: 0.5 mL, Intramuscular (IM) into the anterolateral aspect of the middle third of the left thigh.
- Window: Must be administered within 24 hours of birth to prevent vertical mother-to-child perinatal transmission.
- Oral Poliovirus Vaccine (OPV-0):
- Type: Bivalent live attenuated oral poliovirus vaccine (bOPV: Sabin types 1 and 3).
- Dose & Route: 2 drops orally.
2. At 6, 10, and 14 Weeks
- Pentavalent Vaccine:
- Antigens Combined: Diphtheria toxoid + whole-cell Pertussis vaccine + Tetanus toxoid + recombinant Hepatitis B + Haemophilus influenzae type b conjugate (DPT-HepB-Hib).
- Dose, Route & Site: 0.5 mL, Intramuscular (IM) into the anterolateral aspect of the middle third of the left thigh.
- Schedule: 3 primary doses at 6 weeks, 10 weeks, and 14 weeks.
- Oral Poliovirus Vaccine (OPV 1, 2, 3): 2 drops orally at 6, 10, and 14 weeks.
- Fractional Inactivated Poliovirus Vaccine (fIPV):
- Type: Inactivated (killed, Salk strain) poliovirus vaccine.
- Dose, Route & Site: 0.1 mL, Intradermal (ID) over the right upper arm at the deltoid insertion.
- Schedule: Fractional doses at 6 weeks and 14 weeks, plus a third fIPV dose at 9 completed months (added to the UIP in January 2023 and given with MR-1).
- Rotavirus Vaccine (RVV):
- Type: Live attenuated rotavirus vaccine for prevention of severe rotavirus dehydrating diarrhea.
- Dose & Route: 5 drops orally (liquid suspension) or 2.5 mL according to manufacturer instructions, at 6, 10, and 14 weeks.
- Pneumococcal Conjugate Vaccine (PCV):
- Dose, Route & Site: 0.5 mL, Intramuscular (IM) into the anterolateral aspect of the middle third of the right thigh.
- Schedule: 2 primary doses at 6 weeks and 14 weeks, followed by a booster dose at 9 completed months.
3. At 9 Completed Months
- Measles-Rubella (MR) 1st Dose:
- Type: Live attenuated viral vaccine.
- Dose, Route & Site: 0.5 mL, Subcutaneous (SC) over the right upper arm (deltoid region).
- Diluent: Reconstituted with provided sterile water diluent; must be discarded after 4 hours.
- PCV Booster: 0.5 mL, IM in the anterolateral aspect of the right thigh.
- fIPV-3: 0.1 mL, intradermal, right upper arm (third fractional dose, in the schedule since January 2023).
- Japanese Encephalitis (JE-1): Live attenuated SA 14-14-2 strain. 0.5 mL, SC into the left upper arm (administered only in endemic districts).
- Vitamin A Prophylaxis (1st Dose): 100,000 International Units (IU) = 1 mL administered orally using the supplied calibrated spoon alongside the MR-1 dose.
4. At 16 to 24 Months
- MR 2nd Dose: 0.5 mL, SC, right upper arm.
- DPT 1st Booster: 0.5 mL, IM, anterolateral mid-thigh.
- OPV Booster: 2 drops orally.
- JE-2: 0.5 mL, SC, left upper arm in endemic districts.
- Vitamin A Prophylaxis (2nd Dose): 200,000 IU = 2 mL orally. Administered every 6 months thereafter up to 5 years of age (Total: 9 doses = 17 Lakh IU across childhood: 1 Lakh IU at 9 months + 8 subsequent doses of 2 Lakh IU each).
5. At 5 to 6 Years & Adolescence
- At 5 to 6 Years: DPT 2nd Booster: 0.5 mL, IM into the left upper arm (deltoid muscle).
- At 10 Years and 16 Years: Td (Tetanus & adult Diphtheria toxoid): 0.5 mL, IM into the upper arm deltoid.
- Policy Shift: Td has officially replaced Tetanus Toxoid (TT) across all age groups and maternal schedules in India to prevent waning diphtheria immunity in adolescents and adults.
- Maternal Td Immunization in Pregnancy:
- Td-1: Administered early in pregnancy upon registration.
- Td-2: Administered 4 weeks after Td-1.
- Td Booster: If a pregnant woman has documented receipt of 2 Td doses in a pregnancy within the preceding 3 years, only 1 Td Booster dose is required in the current pregnancy.
4. Cold Chain Logistics, Equipment & Safety Protocols
The Cold Chain is the unbroken system of temperature-controlled storage and transport equipment that maintains vaccines at their biochemically required temperatures from the point of manufacture to the moment of clinical administration.
Temperature Storage Standards
At the PHC, CHC, and district hospital levels, all routine UIP vaccines must be stored strictly within the temperature range of +2°C to +8°C.
Cold Chain Equipment Hierarchy
- Ice-Lined Refrigerator (ILR):
- The primary storage unit at all PHCs and CHCs.
- Top-opening chest refrigerator lined with internal water-filled pipes or ice packs. This top-opening design prevents cold air loss when the lid is opened.
- Its ice lining holds the cabinet within +2°C to +8°C through routine power cuts.
- Internal Placement Rule:
- Top Basket: Holds freeze-sensitive vaccines that are permanently destroyed by freezing: Hepatitis B, Pentavalent, DPT, Td, fIPV, and PCV.
- Bottom Section: Holds heat-sensitive vaccines that tolerate cold: OPV, BCG, and Measles/MR.
- Deep Freezer:
- Operates at -15°C to -25°C.
- At the PHC level, the deep freezer is used solely for freezing ice packs.
- At district and regional stores, deep freezers store bulk OPV.
- CRITICAL SAFETY WARNING: Freeze-sensitive vaccines (Pentavalent, Hepatitis B, Td, PCV) must NEVER be placed inside a deep freezer!
- Vaccine Carriers & Day Carriers:
- Vaccine Carrier: Holds 4 conditioned ice packs; keeps vaccines cold through field immunization clinics and VHND outreach sessions when the lid stays closed.
- Day Carrier: Holds 2 conditioned ice packs; used for short-distance transport and small outreach sessions.
- Conditioning of Ice Packs: Freshly frozen ice packs removed from a deep freezer are at -15°C to -25°C. If unconditioned ice packs are placed in contact with freeze-sensitive vaccines, the vaccines freeze and lose potency. Ice packs must be placed on a flat table at room temperature until frost melts, water droplets form on the exterior, and ice sloshes freely inside when shaken before loading into the carrier.
The Shake Test for Freeze-Sensitive Vaccines
When freeze-sensitive vaccines (Hepatitis B, Pentavalent, Td, PCV) are suspected of having been exposed to sub-zero temperatures, the Shake Test is performed to determine if the aluminum adjuvant has precipitated:
- Test Vial vs. Control Vial: Take the suspected frozen vial ("Test") and select an identical control vial from the same manufacturer that was intentionally frozen solid for 12 hours and then completely thawed ("Control").
- Vigorous Agitation: Vigorously shake both vials simultaneously for 10 to 15 seconds.
- Visual Sedimentation Observation: Place both vials upright side-by-side on an illuminated, flat surface and observe settling over 15 to 30 minutes:
- Damaged (Frozen) Vaccine: In a frozen-damaged vial, the aluminum adjuvant lattice has shattered into large flocculent granules. The sediment settles rapidly to the bottom, leaving a clear, transparent fluid layer above within 15 to 30 minutes.
- Intact (Unfrozen) Vaccine: The adjuvant remains a colloidal suspension. It settles very slowly; fluid remains uniformly cloudy and turbid.
- Interpretation: If the Test vial settles at the same rapid rate as or faster than the frozen Control vial, the Test vial is FREEZE-DAMAGED and MUST BE DISCARDED.
Vaccine Vial Monitor (VVM)
A heat-sensitive chemical indicator label affixed to vaccine vials (printed on UIP vaccine vials; OPV carries the most heat-sensitive VVM type) that changes color under cumulative heat exposure:
- Stage 1: Inner square is distinctly lighter in color than the outer circle Usable.
- Stage 2: Inner square has darkened slightly but remains lighter than the outer circle Usable (prioritize for immediate use).
- Stage 3 (Discard Point): Inner square matches the exact color shade of the outer circle DO NOT USE; DISCARD.
- Stage 4: Inner square is distinctly darker than the outer circle DO NOT USE; DISCARD.
Government of India Open Vial Policy (OVP)
The Open Vial Policy allows opened multi-dose vials of certain vaccines to be stored and used in subsequent immunization sessions for up to 28 days, drastically reducing vaccine wastage.
- Vaccines Eligible for 28-Day Open Vial Use: Multi-dose vials of Hepatitis B, Pentavalent, OPV, fIPV, PCV, and Td.
- Conditions for 28-Day Retention: The expiry date has not passed; the vaccine has been stored continuously at +2°C to +8°C; the VVM inner square has not reached the discard stage; sterile aseptic technique was observed; and the vial septum was never submerged in water.
- STRICT CONTRAINDICATION (Vaccines Excluded from OVP): Reconstituted live vaccines—specifically BCG, Measles-Rubella (MR), and Japanese Encephalitis (JE)—DO NOT fall under the Open Vial Policy. They contain no bacteriostatic preservatives once mixed with diluent. THEY MUST BE DISCARDED WITHIN 4 HOURS OF RECONSTITUTION to avoid severe toxic shock syndrome and secondary bacterial sepsis.
5. Major National Health Programs in India
1. National Health Mission (NHM)
Launched by merging the National Rural Health Mission (NRHM, 2005) and the National Urban Health Mission (NUHM, 2013). NHM aims to achieve universal access to equitable, affordable, and quality healthcare services through community empowerment, decentralized district health planning, and health system strengthening.
2. Janani Suraksha Yojana (JSY)
- Core Mechanism: A safe motherhood intervention launched in 2005 under NHM that provides a conditional cash transfer to incentivize institutional delivery over home delivery. In Low Performing States all pregnant women delivering in government or accredited facilities are eligible; in High Performing States the benefit targets BPL/SC/ST women.
- Cash Assistance in Low Performing States (LPS, including Odisha, Bihar, UP, MP, Rajasthan):
- Rural Areas: Mother receives ₹1,400 + ASHA package ₹600 (₹300 for the antenatal component + ₹300 for facilitating institutional delivery).
- Urban Areas: Mother receives ₹1,000 + ASHA package ₹400.
3. Janani Shishu Suraksha Karyakram (JSSK)
- Launched: June 2011 to eliminate out-of-pocket health expenditures that deter institutional delivery.
- Entitlements for Pregnant Women: Absolutely zero out-of-pocket expense for institutional deliveries and Caesarean sections in all public health facilities, guaranteeing:
- Free normal delivery and free Caesarean sections
- Free drugs and consumables throughout admission
- Free clinical, biochemical, and radiological diagnostics
- Free therapeutic diet during hospital stay (3 days for normal delivery, 7 days for Caesarean section)
- Free provision of blood and blood components
- Completely free transport from home to health facility, inter-facility transfer if referred, and free drop back home
- Absolute exemption from all user charges
- Entitlements for Sick Infants: Extends the exact same zero-expense entitlements (drugs, diagnostics, blood, and transport) to all sick newborns and infants up to 1 year of age treated in public health facilities.
4. Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA)
- Objective: Provides guaranteed, free, comprehensive, and quality antenatal care (ANC) by Medical Officers and private specialist volunteer OBGs on the 9th day of every calendar month to all pregnant women in their 2nd and 3rd trimesters.
- Color-Coded Sticker Triage on Maternal MCP Cards:
- Green Sticker: Normal pregnancy without identified risk factors.
- Red Sticker: High-Risk Pregnancy (e.g., severe anemia, preeclampsia, gestational diabetes, twin gestation, previous Caesarean section).
- Blue Sticker: Pregnancy with gestational hypertension.
- Yellow Sticker: Pregnancy with pregnancy-induced comorbid conditions (diabetes, hypothyroidism).
5. Ayushman Bharat – PM-JAY
Launched in September 2018 as the world's largest government-funded health protection assurance scheme:
- Pillar 1: Creation of 150,000 Ayushman Arogya Mandirs (Health & Wellness Centres) providing Comprehensive Primary Health Care.
- Pillar 2: Pradhan Mantri Jan Arogya Yojana (PM-JAY):
- Provides health assurance coverage of up to ₹5,00,000 (₹5 Lakh) per eligible family per year for secondary and tertiary hospitalization care.
- Fully portable across all empaneled public and private hospitals across India.
- Cashless and paperless access at point of service, with no cap on family size or age.
- Extended from October 2024 to all citizens aged 70 years and above, regardless of income (Ayushman Vay Vandana card).
6. Master Reference Tables: NIS & IPHS Norms
National Immunization Schedule (NIS) Comprehensive Reference
| Age of Infant | Vaccine | Antigen Type | Dose | Route | Anatomical Site | Diluent & High-Yield Exam Points |
|---|---|---|---|---|---|---|
| At Birth | BCG | Live attenuated bacteria (M. bovis) | 0.05 mL (< 1 mo) / 0.1 mL (> 1 mo) | Intradermal (ID) | Left upper arm (deltoid insertion) | Normal saline diluent; discard after 4 hours; protects against TB meningitis and miliary TB. |
| At Birth | Hepatitis B | Recombinant HBsAg | 0.5 mL | Intramuscular (IM) | Anterolateral mid-thigh (Left) | Must be given within 24 hours of birth to block vertical maternal transmission. |
| At Birth | OPV-0 | Live attenuated virus (Sabin 1 & 3) | 2 drops | Oral | Oral mucosa | Birth dose does not count toward the primary 3-dose series. |
| 6, 10, 14 Weeks | Pentavalent | DPT + HepB + Hib | 0.5 mL | IM | Anterolateral mid-thigh (Left) | Adsorbed aluminum adjuvant; freeze-sensitive; shake test if frozen. |
| 6, 10, 14 Weeks | OPV 1, 2, 3 | Live attenuated virus | 2 drops | Oral | Oral mucosa | Heat-sensitive; carries VVM; keep frozen at depot level. |
| 6 & 14 Weeks, 9 Months | fIPV | Killed inactivated virus (Salk) | 0.1 mL | Intradermal (ID) | Right upper arm (deltoid) | Fractional dose (1/5th of the full IM dose); third dose at 9 months added in January 2023. |
| 6, 10, 14 Weeks | Rotavirus | Live attenuated virus | 5 drops | Oral | Oral mucosa | Protects against severe rotavirus acute dehydrating diarrhea. |
| 6 & 14 Weeks | PCV (1 & 2) | Conjugate bacterial polysaccharide | 0.5 mL | IM | Anterolateral mid-thigh (Right) | Primary doses at 6 & 14 weeks; booster at 9 completed months. |
| 9 Months | MR-1 | Live attenuated viral | 0.5 mL | Subcutaneous (SC) | Right upper arm | Sterile water diluent; discard after 4 hours; live virus. |
| 9 Months | PCV Booster | Conjugate bacterial polysaccharide | 0.5 mL | IM | Anterolateral mid-thigh (Right) | Booster dose completing infant pneumococcal series. |
| 9 Months | JE-1 | Live attenuated (SA 14-14-2) | 0.5 mL | SC | Left upper arm | Administered only in endemic districts. Discard after 4 hours. |
| 9 Months | Vitamin A-1 | Retinol palmitate | 100,000 IU (1 mL) | Oral | Oral cavity | 1 mL administered alongside MR-1 to prevent keratomalacia. |
| 16–24 Months | MR-2 | Live attenuated viral | 0.5 mL | SC | Right upper arm | Second scheduled dose of measles-rubella. |
| 16–24 Months | DPT Booster-1 | Toxoids + killed pertussis | 0.5 mL | IM | Anterolateral mid-thigh | First booster dose for childhood diphtheria/pertussis/tetanus. |
| 16–24 Months | OPV Booster | Live attenuated virus | 2 drops | Oral | Oral cavity | Booster dose alongside DPT booster. |
| 16–24 Months | JE-2 | Live attenuated | 0.5 mL | SC | Left upper arm | Second dose in endemic districts. |
| 16–24 Months | Vitamin A (2–9) | Retinol palmitate | 200,000 IU (2 mL) | Oral | Oral cavity | 200,000 IU every 6 months up to 5 years (Total: 9 doses = 17 Lakh IU). |
| 5–6 Years | DPT Booster-2 | Toxoids + killed pertussis | 0.5 mL | IM | Upper arm (deltoid muscle) | Second booster dose for school entry. |
| 10 & 16 Years | Td | Tetanus + adult Diphtheria | 0.5 mL | IM | Upper arm deltoid | Replaced TT; given at age 10 and 16 years. |
Indian Public Health Standards (IPHS) Rural Infrastructure Norms
| Level of Facility | Population Norm (Plain) | Population Norm (Hilly / Tribal) | Inpatient Beds | Key Healthcare Personnel | Core Clinical Mandate & Referral Linkage |
|---|---|---|---|---|---|
| Sub-Centre / Ayushman Arogya Mandir | 5,000 | 3,000 | Nil (or 2 labor observation beds) | ANM (Female), MPW-M (Male), CHO (B.Sc Nursing / GNM) | 12 Comprehensive Primary Health Care packages, UIP vaccination, ANC, NCD screening, tele-consultation. First contact point. |
| Primary Health Centre (PHC) | 30,000 | 20,000 | 4 to 6 beds | Medical Officer (MBBS), 3–5 Staff Nurses, Pharmacist, Lab Technician | 24/7 basic emergency obstetric care (BEmONC), routine curative OPD/IPD, minor surgeries. Referral link for 6 Sub-Centres. |
| Community Health Centre (CHC) | 120,000 | 80,000 | 30 beds | 4 Specialists (Surgeon, Physician, Gynecologist, Pediatrician), 10 Staff Nurses | First Referral Unit (FRU) when providing 24/7 CEmONC, Caesarean sections, operational blood storage, and sick newborn care. Link for 4 PHCs. |
A community health nurse conducting an outreach Village Health and Nutrition Day (VHND) opens multiple vaccine vials. In accordance with the Government of India's Universal Immunization Programme Open Vial Policy, which of the following reconstituted vaccines MUST be discarded within 4 hours of reconstitution?
BCG, Measles-Rubella (MR) and Japanese Encephalitis (JE)
Oral Poliovirus Vaccine, Pneumococcal Conjugate Vaccine and Td
Hepatitis B, Pentavalent and Inactivated Poliovirus Vaccine
Rotavirus liquid vaccine and fractional Inactivated Poliovirus Vaccine
Under the Indian Public Health Standards (IPHS) norms for rural healthcare infrastructure, what is the designated population norm for establishing a Primary Health Centre (PHC) in plain areas versus hilly, tribal, or difficult terrain?
50,000 in plain areas and 40,000 in hilly/tribal areas
30,000 in plain areas and 20,000 in hilly/tribal areas
5,000 in plain areas and 3,000 in hilly/tribal areas
120,000 in plain areas and 80,000 in hilly/tribal areas
A staff nurse is preparing to administer the Bacillus Calmette-Guérin (BCG) vaccine to a healthy newborn prior to discharge from the maternity ward. What is the correct standard dose, route, and anatomical site of administration for BCG at birth?
0.1 mL, subcutaneously in the right upper arm over the triceps
2 drops, orally administered into the buccal mucosa
0.5 mL, intramuscularly in the anterolateral aspect of the left thigh
0.05 mL, intradermally in the left upper arm over the deltoid insertion
Sections you finish are checked off in the contents.